Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage

Glaucoma etiology often includes retinal ganglion cell (RGC) death associated with elevated intraocular pressure (IOP). However, even when IOP is managed well, disease can progress. It is thus important to develop therapeutic approaches that directly protect RGCs in an IOP-independent manner. Compro...

Description complète

Détails bibliographiques

Auteurs principaux:	Xian Zhang, Nan Zhang, Micah A. Chrenek, Preston E. Girardot, Jiaxing Wang, Jana T. Sellers, Eldon E. Geisert, Charles Brenner, John M. Nickerson, Jeffrey H. Boatright, Ying Li
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2021-06-01
Collection:	Pharmaceutics
Sujets:	nicotinamide riboside retinal ganglion cell neuroprotection microbead optic nerve crush ERG
Accès en ligne:	https://www.mdpi.com/1999-4923/13/6/893
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!